Atlas Trials

A Study of the Safety and Pharmacology of MEGF0444A in Combination With Bevacizumab With or Without Paclitaxel in Patients With Locally Advanced or Metastatic Solid Tumors

Clinical trial NCT01075464 · COMPLETED

Trial details

NCT number
NCT01075464
Sponsor
Genentech, Inc.
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Solid Cancers
Start date
2010-02-01
Primary completion
2013-04-01
Enrollment
64

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.